Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoproteinE genotype dependent
U. Beffert et al., Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoproteinE genotype dependent, BRAIN RES, 843(1-2), 1999, pp. 87-94
The epsilon 4 allele of apolipoprotein E (apoE) is associated with increase
d risk for the development of Alzheimer's disease (AD), possibly due to int
eractions with the beta-amyloid (A beta) protein. The mechanism by which th
ese two proteins are linked to AD is still unclear. To further assess: thei
r potential relationship with the disease, we have determined levels of apo
E and A beta isoforms from three brain regions of neuropathologically confi
rmed AD and non-AD tissue. In two brain regions affected by AD neuropatholo
gy, the hippocampus and frontal cortex, apoE levels were found to be decrea
sed while A beta(1-40) levels were increased. Levels of apoE were unchanged
in AD cerebellum. Furthermore, levels of apoE and A beta(1-40) were found
to be apoE genotype:dependent, with lowest levels of apoE and highest level
s of A beta(1-40) occurring in epsilon 4 allele carriers. These results sug
gest that reduction in apoE levels may give rise to increased deposition of
amyloid peptides in AD brain. (C) 1999 Published by Elsevier Science B.V.
All rights reserved.